MedTrace Logo

Effects of a Yeast Fermentate (EpiCor) Supplement on Cold or Flu Symptoms in Healthy Children

NCT05492370 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 256

Last updated 2023-11-18

No results posted yet for this study

Summary

This is a double-blind, randomized, placebo-controlled study. The purpose of the clinical study is to determine the difference between 84 days of once daily oral EpiCor supplementation compared to placebo on the incidence of cold or flu symptoms among children aged 4-12 years who are attending school or daycare.

Conditions

  • Signs and Symptoms, Respiratory

Interventions

DIETARY_SUPPLEMENT

EpiCor

2 gummies daily

DIETARY_SUPPLEMENT

Placebo

2 gummies daily

Sponsors & Collaborators

  • KGK Science Inc.

    collaborator INDUSTRY

  • Cargill

    lead INDUSTRY

Principal Investigators

  • David Crowley, MD · KGK Science

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-07
Primary Completion
2023-04-18
Completion
2023-07-19

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05492370 on ClinicalTrials.gov